pfizer vaccine

The CDC voted Thursday to recommend updated versions of both the Pfizer and Moderna coronavirus vaccine boosters, paving way for a widespread rollout as early as next week.

Miami-Dade County has announced a vaccine drive for children six months and older this weekend following the U.S. Food and Drug Administration’s approval of vaccines for young children. The pediatric vaccine drive is being hosted in partnership with Nomi Health, the company that is providing testing and vaccines for several sites throughout the county. The event will take from...

A look at what parents need to know about COVID-19 vaccines for kids under 5.

The FDA authorized the first COVID-19 vaccination for children as young as six months on Friday. A panel of CDC advisors will vote Saturday, meaning shots for infants and preschoolers could be available as early as next week.

An analysis from the U.S. Food and Drug Administration states that kid-sized doses of Pfizer’s COVID-19 vaccine appears safe and effective for children under five, which would be a huge step towards vaccinating the nation’s youngest children who were previously unprotected.

Pfizer says it will seek emergency use authorization for a three-dose course of its COVID-19 vaccine in pediatric patients ages 6 months to 5 years old after publishing data from it’s latest study.

The FDA announced Tuesday that it has expanded eligibility for the Pfizer booster shot to include children ages 5 to 11.

Pfizer and its partner BioNTech said Thursday new data shows its kid-sized booster shot helps healthy 5- to 11-year-olds rev up virus-fighting antibodies.

The U.N.-backed Medicines Patent Pool says that nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill

Pfizer asked the FDA Tuesday to authorize a second booster dose of its COVID-19 vaccine for Americans ages 65 and over.

German vaccine maker BioNTech unveiled plans Wednesday to establish manufacturing facilities in Africa that would boost the availability of much-needed medicines on the continent

The FDA and CDC granted authorization on Thursday for Pfizer’s COVID-19 booster for 16- and 17-year-olds.